Minimal effective dose of oral bedaquiline and activity of a long acting formulation of bedaquiline in the murine model of leprosy
A. Chauffour, N. Lounis, K. Andries, V. Jarlier, N. Veziris, A. Aubry
This study determines the minimal effective dose of oral bedaquiline and evaluates the efficacy of a long-acting injectable formulation in a murine model of leprosy, finding that the MED is 3.3 mg/kg and the injectable form is less effective than oral administration.
bioRxiv · May 15, 2023 · PreprintMicrobiology